LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Kodu・Aktsiate loetelu・Abbott Laboratories

Abbott Laboratories

Suletud

Sektor Tervishoid

113.86 0.79

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

113.55

Max

114.24

Põhinäitajad
By Trading Economics
Sissetulek	77M 1.3B
Müük	420M 10B
P/E Sektori keskmine	32.37 103.001
Aktsiakasum	1.14
Kasumimarginaal	12.543
Töötajad	114,000
EBITDA	170M 2.6B

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+12.36 upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	16. okt 2024
Järgmine dividendimakse kuupäev	13. nov 2024
Järgmine aktsia dividendi kuupäev (ex-date)	10. okt 2024

Turustatistika
By TradingEconomics
Turukapital	197B
Eelmine avamishind	113.07
Eelmine sulgemishind	113.86

Uudiste sentiment

By Acuity

59%

41%

278 / 365 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bearish Evidence

113.255 / 114.66 Toetus ja vastupanu

Abbott Laboratories Graafik

Seotud uudised

29. juuli 2024, 10:30 UTC

Suurimad hinnamuutused turgudel

Abbott Laboratories Shares Tumble on $495 Million Infant Formula Verdict

29. juuli 2024, 09:27 UTC

Suurimad hinnamuutused turgudel

Reckitt Benckiser Shares Tumble on Abbott's Baby-Formula Litigation

18. juuli 2024, 12:21 UTC

Tulu

Abbott Labs Lifts FY24 Outlook After 2Q Sales Rise

29. juuli 2024, 10:15 UTC

Suurimad hinnamuutused turgudel

Abbott Laboratories Shares Tumble on $495 Mln Infant Formula Verdict

29. juuli 2024, 08:50 UTC

Kuumad aktsiad

Stocks to Watch Monday: Coinbase, Abbott, McDonald's, Heineken -- WSJ

18. juuli 2024, 19:04 UTC

Market Talk

Tulu

Abbott CEO Warns of Health Crisis if Preterm Formula Pulled -- Market Talk

18. juuli 2024, 11:43 UTC

Tulu

Abbott Laboratories Earnings Top Views, Full-Year Guidance Raised -- IBD

18. juuli 2024, 11:34 UTC

Tulu

Abbott Labs Sees 3Q Adj EPS $1.18-Adj EPS $1.22 >ABT

18. juuli 2024, 11:34 UTC

Tulu

Abbott Labs Sees 3Q EPS 85c-EPS 89c >ABT

18. juuli 2024, 11:31 UTC

Tulu

Abbott Labs Narrows FY24 Organic Sales Growth View, Ex-COVID-19 Testing-Related Sales, to 9.5% to 10% >ABT

18. juuli 2024, 11:30 UTC

Tulu

Abbott Labs Sees FY Adj EPS $4.61-Adj EPS $4.71 >ABT

18. juuli 2024, 11:30 UTC

Tulu

Abbott Labs Sees FY EPS $3.30-EPS $3.40 >ABT

18. juuli 2024, 11:30 UTC

Tulu

Abbott Labs 2Q Organic Sales Growth Up 7.4% >ABT

18. juuli 2024, 11:30 UTC

Tulu

Abbott Labs 2Q Sales $10.38B >ABT

18. juuli 2024, 11:30 UTC

Tulu

Abbott Labs 2Q Adj EPS $1.14 >ABT

18. juuli 2024, 11:30 UTC

Tulu

Abbott Labs 2Q Net $1.3B >ABT

18. juuli 2024, 11:30 UTC

Tulu

Abbott Labs 2Q EPS 74c >ABT

18. juuli 2024, 11:30 UTC

Tulu

Abbott Raises Full-Yr Guidance

14. juuli 2024, 22:41 UTC

Tulu

Stocks Poised for Higher Open -- Barrons.com

12. juuli 2024, 23:29 UTC

Omandamised, ülevõtmised, äriostud

BP Says Oil Demand Is Falling, While OPEC Says It's Rising. What Gives? -- Barrons.com

17. apr 2024, 13:54 UTC

Tulu

Abbott Labs Stock Is Slipping After Earnings Beat. Here's Why. -- Barrons.com

17. apr 2024, 12:41 UTC

Peamised uudised

Tulu

Abbott Labs Stock Is Slipping. Disappointing Guidance Trumps a Strong Quarter. -- Barrons.com

17. apr 2024, 11:52 UTC

Tulu

Abbott Labs Jumps, Retreats On Q1 Beat, Shy Guidance -- IBD

17. apr 2024, 11:45 UTC

Tulu

Abbott Labs First-Quarter Results Top Estimates Amid Strong Medical Device Sales -- MarketWatch

17. apr 2024, 11:32 UTC

Tulu

Abbott Labs Narrows 2024 Organic Sales Growth Ex-Covid-19 View to 8.5%-10% >ABT

17. apr 2024, 11:30 UTC

Tulu

Abbott Labs 1Q Organic Sales for Underlying Base Business Rose 10.8% >ABT

17. apr 2024, 11:30 UTC

Tulu

Abbott Raises Midpoint of Full-Year Guidance Ranges >ABT

17. apr 2024, 11:30 UTC

Tulu

Abbott Labs Sees FY Adj EPS $4.55-Adj EPS $4.70 >ABT

17. apr 2024, 11:30 UTC

Tulu

Abbott Labs 1Q Adj EPS 98c >ABT

17. apr 2024, 11:30 UTC

Tulu

Abbott Labs 1Q EPS 70c >ABT

Võrdlus sarnastega

Hinnamuutus

Abbott Laboratories Prognoos

Hinnasiht

By TipRanks

12.36% tõus

12 kuu keskmine prognoos

Keskmine 127.08 USD 12.36%

Kõrge 143 USD

Madal 107 USD

Põhineb 14 Wall Streeti analüütiku instrumendi Abbott Laboratories 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

14 ratings

Osta

Hoia

Müü

Põhineb 14 analüütiku instrumendi Abbott Laboratories aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

113.255 / 114.66Toetus ja vastupanu

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Sentiment

By Acuity

278 / 365 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Abbott Laboratories

Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its products include a line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The Company’s products are sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses. It offers cardiovascular and metabolic products, including Lipanthyl, TriCor, Teveten, Teveten Plus, Physiotens, and Synthroid.